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Background: Chronic Kidney Disease (CKD) and inflammation are risk factors for atherosclerotic vascular disease
(ASVD). In inflammatory conditions, Nuclear Factor-κB (NF-κB) is frequently activated and it has been detected in
human ASVD. In this work, we investigated if the degree of inflammation and of NF-κB activation were increased in
the aorta of patients with CKD.
Methods: This is a case–control pilot study performed on 30 abdominal aorta samples from 10 human autopsies.
Cases were patients with CKD and controls patients with normal glomerular filtration rate (eGFR). Infiltrating
mononuclear cells (S100+, CD3+, CD40+, CD40L+) and activation of NF-κB were identified by immunohistochemistry.
Findings: The number of cells in the intima which showed activated nuclear NF-κB correlated with severity of ASVD
lesions (r = 0.56, p = 0.003), with numbers of CD3+ lymphocytes in adventitia (r = 0.50, p = 0.008), with numbers of
CD40+ cells in the intima (r = 0.59, p = 0.002) or in the adventitia (r = 0.45, p = 0.02), and with numbers of CD40L+
cells in the intima (r = 0.51, p = 0.011). Increased numbers of S100+ Intimal Dendritic cells (IDCs) were associated
with ASVD (p = 0.03) and CKD (p = 0.01).
Conclusions: Number of CD3+ cells, of CD40+ cells, of CD40L+ cells and the degree of NF-κB activation were
increased in ASVD lesions suggesting a role for the adaptive T cell in the development of ASVD lesions. IDCs were
associated both with ASVD and CKD suggesting a role of these cells in the pathogenesis of ASVD in CKD.
Keywords: Atherosclerosis, Chronic kidney disease, Inflammation, Nuclear factor-k B, Dendritic cellsFindings
Atatement of the research
The higher incidence of atherosclerotic vascular disease
(ASVD) in CKD could result from systemic and/or local
vascular inflammation, in which activated T lymphocytes
would play a critical role, since their deficiency in a mouse
model has been shown to lead to a marked reduction of
lesions, while their adoptive transfer reconstituted the
disease [1]. Activation of T lymphocytes requires a second
signal provided by costimulatory molecules expressed in
the membrane of antigen presenting cells (APC). CD40
and its ligand CD40L (CD154) are critical components of* Correspondence: mhueso@idibell.cat
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unless otherwise stated.the costimulatory pathway. CD40/CD40L signalling oc-
curs via activation of NF-κB (Nuclear Factor-κB) which
activates many of the genes involved in the inflammatory
response that are pivotal in the pathogenesis of vascular
injury [2]. Consequently, activated NF-κB has been de-
tected in a rabbit model of ASVD [3] and in human ASVD
but not in normal vessels [4]. Furthermore, activation of
NF-κB has been also involved in the progression of renal
tubulointerstitial lesions in experimental proteinuric ne-
phropathies and in the development of human glomerulo-
nephritis [5], a possible link between CKD and ASVD.
In this work we have studied the adaptive immune re-
sponse in the aortic wall of patients with CKD, with the
aim to explain the high incidence of ASVD in patients
with CKD.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinical characteristics of patients
ID Age Gender Cause of death Diabetes Hypertension Dyslipidemia Creatinine (μmol/L) eGFR (mL/min) Histology CKD stage
1 60 Female Cardiovascular No yes No Dialysis FSGS + IF-TA 5D
2 83 Female Cardiovascular No yes No 66 >60 IF-TA No
3 83 Male Cancer Yes Yes No 219 25 FSGS + IF-TA 4
4 68 Female Cancer No No No 83 >60 Normal No
5 49 Male Cardiovascular No Yes Yes 327 17 FSGS + IF-TA 4
6 60 Female Cardiovascular Yes Yes Yes 84 >60 Normal No
7 68 Female Infection No Yes No 130 35 IF-TA 3
8 76 Male Infection Yes Yes No 48 >60 multicystic No
9 86 Female Cardiovascular No Yes No 169 21 FSGS + IF-TA 4
10 85 Female Cardiovascular Yes Yes No 66 >60 FSGS No
Abbreviations:
ID: Identification Number.
eGFR: estimated Glomerular Filtration Rate.
CKD: Chronic Kidney Disease.
FSGS: focal segmental glomerulosclerosis.
IF-TA: Interticial Fibrosis and Tubular Atrophy.
Table 2 Relative proportions of infiltrating cells in aorta
samples from all patients classified according to the
modified classification of AHA
AIT PIT FA
Mab Location n = 10 n = 10 n = 10 p
αCD3 Intima 12 ± 9% 20 ± 9% 29 ± 6%t 0.005
Adventitia 8 ± 6% 21 ± 23% 22 ± 14% 0.02
αS100 Intima 5 ± 5% 7 ± 7% 13 ± 6% 0.03
Adventitia 11 ± 9% 9 ± 5% 9 ± 3% 0.97
αCD40 Intima 35 ± 20% 69 ± 17%t 73 ± 14%t 0.003
Adventitia 59 ± 19% 77 ± 14% 71 ± 12% 0.05
αCD40L Intima 30 ± 16% 59 ± 22%* 61 ± 25%* 0.01
Adventitia 51 ± 15% 52 ± 20% 47 ± 13% 0.86
αNF-κB Intima 14 ± 16% 45 ± 28%* 54 ± 25%t 0.01
Adventitia 12 ± 9% 46 ± 35%* 40 ± 18% 0.01
For each case we calculated the number of CD3+, S100+, CD40+, CD40L+ and
NF-κB+ infiltrating cells as percentage of total cells and expressed the result as
the mean ± SD.
*P < 0.05 vs AIT (Bonferroni Test); tP < 0.01 vs AIT (Bonferroni test)
Abbreviations:
AIT: adaptive intimal thickening,
PIT: pathological intimal thickening,
FA: fibroatheroma.
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Study design
This is a case–control, pilot study using aortas from pa-
tients deceased in the Hospital Universitari de Bellvitge
(HUB, 11/2009-02/2010). Cases were stage 3 (or higher)
CKD patients at the time of hospital admission. Controls
were patients, deceased in the same time-period, with a
normal eGFR (estimated glomerular filtration by the
“Modification of Diet in Renal Disease” simplified equa-
tion). The presence of CKD was confirmed by histological
examination.
Ethics statement
In this work, we have used authorized autopsy material
from the Department of Pathology of the Hospital
Universitari Bellvitge (HUB). Confidential information
from patients was protected following national norma-
tives. This manuscript has been revised by the Clinical
Research Ethics Committee of the HUB.
Immunohistochemistry
Three samples were isolated from each patient: macroscop-
ically normal abdominal aorta, incipient ASVD lesion, and
a complicated lesion. Sections were H/E-stained and classi-
fied according to the modified classification of American
Heart Association (AHA) [6]. Formalin-fixed, paraffin-
embedded aortas, were sliced at 4 μm and stained with
polyclonal anti-CD3, anti-S100 (Dako, Glostrup, Denmark),
anti-CD40, anti-CD40L (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and anti-NF-κB-p65 (phosphor S536)
(Abcam, Cambridge, UK) antibodies. Sections were coun-
terstained with hematoxylin to make nuclei evident.
Human parotid glands or ganglions were used as positive
controls. Isotype controls were performed using antibodybuffer supplemented with irrelevant immunoglobulines of
the same isotype, species and concentration as the
primary antibody (ThermoFisher, Rockford, IL USA).
Negative controls were performed by omitting primary
antibodies. Positively stained cells were counted at x100 to
x200 and acquired with a digital camera. The percentage
of positive cells was assessed irrespective of the staining
intensity. Results were expressed as the percentage of each
population regarding the total number of cells in the
intima or adventitia.
Figure 1 (See legend on next page.)
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Figure 1 Increased number of CD3+ T-lymphocytes and IDCs in areas of progressive ASVD lesions. A. CD3+ T-lymphocytes detected in
the endothelium and subendothelial zones of aortas with PIT or FA (arrows). Magnifications as indicated. B. Box-plot showing percentage of CD3
+ T-lymphocytes, regarding the total number of cells in the field, according to histological lesion. Kruskal-Wallis test. C. S100+ IDCs, localized in
the intima of aortas according to histological lesion. Kruskal-Wallis test. Magnifications as indicated. D. Box-plot showing percentage of S-100+IDCs
according to histological lesion. Kruskal-Wallis test. E. S100+ IDCs, localized in the intima of aortas grouped according to histological lesions
and presence of CKD. Magnifications as indicated. F. Box-plot showing percentage of S100+IDCs according to CKD and with independence of
histological lesion. Mann–Whitney test. In figures B, D and F, each diagram represents the median, quartiles and outliers. The colored box represents
the interquartile range that contains 50% of the values. The whiskers are lines that extended from the box to the highest and lowest values, excluding
outliers. A line across the box represents the median value.
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Cell infiltration was measured as the mean of scores ±
standard deviation. Differences in cell infiltration between
arterial lesions were compared by the Kruskal-Wallis test.
Mann–Whitney test was used to compare differences in
cell infiltration in CKD patients. Correlation among CD3,
S100, CD40, CD40L and NF-κB scores in ASVD le-
sions against the presence of CKD was performed with
the Spearman rank correlation coefficient. A p <0.05 value
was considered statistically significant. P values were
corrected for the number of variables compared ac-
cording to the Bonferroni method. Statistical analysis was
performed using the SPSS 12.0 software (SPSS Inc.
Chicago, IL).
Results and discussion
Atherosclerotic vascular disease (ASVD) is more com-
mon and more severe in CKD patients than in the gen-
eral population [1,7] and ASVD lesions grow faster in anTable 3 Relative proportions of infiltrating cells in aorta samp
modified classification of American Heart Association (AHA)
Non-CKD
AIT PIT FA
Mab Location n = 5 n = 5 n = 5
αCD3 intima 10 ± 9% 18 ± 10% 25 ± 5%
adventitia 8 ± 5% 11 ± 5% 22 ± 11%
αS100 intima 3 ± 1% 3 ± 1% 11 ± 7%
adventitia 10 ± 10% 8 ± 5% 8 ± 3%
αCD40 intima 38 ± 19% 70 ± 15%* 84 ± 6%t
adventitia 61 ± 10% 69 ± 15% 76 ± 6%
αCD40L intima 28 ± 18% 51 ± 22% 69 ± 31%
adventitia 46 ± 16% 40 ± 15% 53 ± 14%
αNF-κB intima 10 ± 18% 49 ± 30% 46 ± 17%
adventitia 11 ± 11% 58 ± 35%* 31 ± 6%
For each case we calculated the number of CD3+, S100+, CD40+, CD40L+ and NF-κB
the mean ± SD.
*P < 0.05 vs AIT (Bonferroni Test); tP < 0.005 vs AIT (Bonferroni test).
Abbreviations:
AIT: adaptive intimal thickening,
PIT: pathological intimal thickening,
FA: fibroatheroma.
CKD: Chronic kidney Diseaseuremic environment [8] suggesting a pathogenic link.
Since inflammation seems critical in the development of
ASVD pathogenesis [9], the higher incidence of ASVD
in CKD could result from systemic and/or local vascular
inflammation. Thus, we present a pilot study in 30 sam-
ples from abdominal aortas, obtained from 10 deceased
patients (Table 1) to investigate whether the abdominal
aorta from CKD patients presented features of enhanced
inflammation that would justify the increase in ASVD le-
sions observed in these patients.
A few infiltrating CD3+ cells were found in the intima of
aortas with adaptive intimal thickening (AIT) with their
number increasing significantly in areas with pathological
intimal thickening (PIT) or with fibroatheroma (FA)
(Table 2), and correlating with the severity of the ASVD
lesions (Figure 1A and B). These results are not surprising
since inflammation seems to have a critical role in ASVD
pathogenesis [9], subsequent to the development of mal-
adaptive vascular inflammation as well as to the failure ofles grouped according to presence of CKD and to the
CKD
AIT PIT FA
p n = 5 n = 5 n = 5 p
0.05 14 ± 12% 23 ± 11% 33 ± 6% 0.06
0.14 7 ± 8% 31 ± 31% 23 ± 18% 0.07
0.11 8 ± 6% 11 ± 8% 16 ± 5% 0.22
0.85 13 ± 9% 9 ± 5% 9 ± 5% 0.78
0.01 30 ± 26% 66 ± 25% 65 ± 12% 0.11
0.16 57 ± 29% 86 ± 7% 66 ± 16% 0.07
0.08 35 ± 14% 70 ± 20% 51 ± 15% 0.06
0.46 58 ± 12% 68 ± 16% 40 ± 9% 0.09
0.07 19 ± 12% 42 ± 29% 62 ± 32% 0.11
0.03 14 ± 9% 31 ± 32% 62 ± 18% 0.22
+ infiltrating cells as percentage of total cells and expressed the result as
Figure 2 Increased activation of NF-κB in progressive ASVD lesions. A. Activated NF-κB-p65 detected in the intima of aortas with PIT or FA
by immunostaining with anti phospho S536. Sample with AIT did not show activation of NF-κB Magnifications as indicated. B. Box-plot showing
percentage of cells with activated NF-κB in the intima, regarding the total number of cells in the field, according to histological lesion.
Kruskal-Wallis test. C.- Activated NF-κB-p65 detected in the adventitia of aortas with PIT or FA by immunostaining with anti-phospho
S536. Activation of NF-κB was detected in endothelial cells (ECs), smooth muscle cells (SMCs) and lymphocytes (L). Sample with AIT did
not show activation of NF-κB. Magnifications as indicated. D.- Box-plot showing percentage of cells with activated NF-κB in the adventitia,
regarding the total number of cells in the field, according to histological lesion. Kruskal-Wallis test.
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to the deposition and modification of low-density lipopro-
teins within arterial walls [10].
Since Dendritic Cells (DCs) are key sensors of the in-
nate and the adaptive arms of the immune system, we
analyzed their presence in the aortic wall. There are sev-
eral markers for the identification of DCs but it has been
suggested that S100 is the most reliable marker for the
visualization of the major portion of DC population in
the human arterial intima [11]. Although S100 is not ex-
clusively specific to DC and it is expressed by neural
cells, S100 specifically identifies DC in the arterial intima
because the intima and two-thirds of the internal part of
the tunica media are not innervated [12]. The proportion
of S100+ Intimal Dendritic Cells (IDCs) was also increased
in progressive ASVD lesions (Table 2 and Figure 1C) and
in patients with CKD (11 ± 6% of IDCs in CKD aortas vs.
5 ± 5% in aortas without CKD, p = 0.01; Figure 1E and F),
suggesting a role of these cells in the pathogenesis of
ASVD in CKD. Other works have detected IDCs inatherogenic susceptible regions in the aorta of rabbits
and mice, in which their abundance was correlated with
a genetic susceptibility of mice to ASVD [13]. On the con-
trary depletion of IDCs was shown to reduce intimal lipid
accumulation, indicating that IDCs would be involved
in the formation of nascent atherosclerotic lesions [14].
Furthermore, it has been suggested that a proinflamma-
tory environment, such as CKD, might promote IDCs ac-
cumulation and predispose these regions to ASVD [13].
The origin of IDCs and the physiological role of IDCs in
the normal aorta is still unknown. IDCs isolated from
the aorta and valves of mice have the capacity to cross-
present antigen to CD8+T cells in vitro, but the scarcity of
T-cells in the aortic intima suggests that antigen presenta-
tion would not be their primary function. In this sense, it
has been recently suggested that initial foam cells in early
lesions would derive primarily from IDCs rather than
from newly recruited monocytes [13].
AIT lesions showed scanty CD40+-expressing cells in
the intima with their numbers increasing in areas with
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the adventitia according to the severity of the lesions
(Table 2). In addition, the proportion of CD40L+ infil-
trating cells was increased in progressive ASVD lesions
(Table 2) and CD40L+ expression was induced in endo-
thelial cells of vasa vasorum suggesting an endothelial
activation. These data are not surprising because the CD40/
CD40L system has been already implicated in ASVD
pathogenesis [15]. However, no relationship could be estab-
lished with CKD in this work (Table 3).
Since NF-κB is a downstream target of CD40/CD40L
signalling we analysed NF-κB activation in the progres-
sive ASVD lesions, as well as its association with the ac-
cumulation of inflammatory cells, by using an antibody
specific for the phospho-S536 form of NF-κB-p65 (see
Methods). Activation of NF-κB was detected in endothe-
lial cells (ECs), smooth muscle cells (SMCs) and lympho-
cytes (Figure 2A, second and third panels). Furthermore,
numbers of activated NF-κB+ cells in the intima correlated
positively with the severity of ASVD lesions (r = 0.56, p =
0.003) (Figure 2), and with the percentage of CD3+ cells in
the adventitia (r = 0.50, p = 0.008), of CD40+ cells (r = 0.59,
p = 0.002 in the intima, and r = 0.45, p = 0.02 in the adven-
titia), and of CD40L+ cells (r = 0.44, p = 0.03 in the intima).
No differences were detected in the number of activated
NF-κB+ cells in aortas from CKD patients vs. controls
without CKD.
In summary, our study showed an accumulation of in-
filtrated CD3+ lymphocytes, of CD40+ cells as well as an
increase in the activation of NF-κB associated to pro-
gressive ASVD lesions in the abdominal aorta. The arter-
ial wall of abdominal aorta displayed an increase
number of intimal dendritic cells (IDCs) in patients with
CKD suggesting a role of these cells in the pathogenesis
of ASVD in CKD.
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